Literature DB >> 2024274

Angiographic vasospasm and release of platelet thromboxane after subarachnoid hemorrhage.

S Juvela1, J Ohman, A Servo, O Heiskanen, M Kaste.   

Abstract

We studied adenosine diphosphate-induced platelet aggregation and the associated release of thromboxane B2 in 49 patients with subarachnoid hemorrhage in relation to angiographic vasospasm. Postoperative cerebral angiography was performed less than or equal to 3 (median 1) days after surgery for an aneurysm 5-14 days after subarachnoid hemorrhage. Correspondingly, one sample from each patient was taken within 24 hours either before or after angiography. The occurrence of severe as well as diffuse, moderate, or severe angiographic vasospasm was associated with the presence of delayed cerebral ischemia (p less than 0.05). Patients with diffuse angiographic vasospasm had significantly higher (p less than 0.05) values for thromboxane B2 release than the others, even after adjustment by the clinical grades on admission and before surgery, the timing of surgery, the time from subarachnoid hemorrhage to angiography and blood sampling, and nimodipine therapy. Severe and diffuse angiographic vasospasm were also associated with poor outcome at 1 year (p less than 0.05). Our results suggest that augmented release of platelet thromboxane may be involved in the pathogenesis of vasospasm in large cerebral arteries.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2024274     DOI: 10.1161/01.str.22.4.451

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  7 in total

1.  Plasma ADAMTS13 activity and von Willebrand factor antigen and activity in patients with subarachnoid haemorrhage.

Authors:  Monisha Kumar; Wenjing Cao; Jenny K McDaniel; Huy P Pham; Dheeraj Raju; Kelsey Nawalinski; Suzanne Frangos; David Kung; Eric Zager; Scott E Kasner; Joshua M Levine; X Long Zheng
Journal:  Thromb Haemost       Date:  2017-01-19       Impact factor: 5.249

2.  In vitro analysis of platelet function in acute aneurysmal subarachnoid haemorrhage.

Authors:  Christian von der Brelie; Alexander Subai; Verena Limperger; Veit Rohde; Astrid Dempfle; Azize Boström
Journal:  Neurosurg Rev       Date:  2017-07-24       Impact factor: 3.042

Review 3.  Nimodipine. A review of its pharmacological properties, and therapeutic efficacy in cerebral disorders.

Authors:  A N Wadworth; D McTavish
Journal:  Drugs Aging       Date:  1992 Jul-Aug       Impact factor: 3.923

4.  Vasospasm following aneurysmal subarachnoid hemorrhage: Thrombocytopenia a marker.

Authors:  Ashish Aggarwal; Pravin Salunke; Harnarayan Singh; Sunil Kumar Gupta; Rajesh Chhabra; Navneet Singla; Ashwani Kumar Sachdeva
Journal:  J Neurosci Rural Pract       Date:  2013-07

5.  Eicosapentaenoic acid (EPA)-induced inhibitory effects on porcine coronary and cerebral arteries involve inhibition of prostanoid TP receptors.

Authors:  Kento Yoshioka; Keisuke Obara; Shunya Oikawa; Kohei Uemura; Akina Yamaguchi; Kazuki Fujisawa; Hitomi Hanazawa; Miki Fujiwara; Taison Endoh; Taichi Suzuki; Montserrat De Dios Regadera; Daichi Ito; Noboru Saitoh; Yutaka Nakagome; Toma Yamashita; Mayu Kiguchi; Yuka Saito; Yuri Nakao; Hinako Miyaji; Guanghan Ou; Keyue Xu; Yoshio Tanaka
Journal:  Sci Rep       Date:  2022-07-27       Impact factor: 4.996

Review 6.  Role of platelets in the pathogenesis of delayed injury after subarachnoid hemorrhage.

Authors:  Ari Dienel; Peeyush Kumar T; Spiros L Blackburn; Devin W McBride
Journal:  J Cereb Blood Flow Metab       Date:  2021-06-10       Impact factor: 6.960

7.  Effects of post-interventional antiplatelet therapy on angiographic vasospasm, delayed cerebral ischemia, and clinical outcome after aneurysmal subarachnoid hemorrhage: a single-center experience.

Authors:  Claudia Ditz; Björn Machner; Hannes Schacht; Alexander Neumann; Peter Schramm; Volker M Tronnier; Jan Küchler
Journal:  Neurosurg Rev       Date:  2021-01-25       Impact factor: 3.042

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.